Progress to Reverse Blindness Reported

Topic: Blindness and Vision Loss
Author: Indiana University-Purdue University Indianapolis School of Science
Published: 2011/06/15
Contents: Summary - Introduction - Main Item - Related Topics

Synopsis: May lead to therapies to reverse blindness caused by common retinal diseases such as macular degeneration and retinitis pigmentosa.

Introduction

Researchers report progress using iPS cells to reverse blindness...

Main Item

Researchers have used cutting-edge stem cell technology to correct a genetic defect present in a rare blinding disorder, another step on a promising path that may one day lead to therapies to reverse blindness caused by common retinal diseases such as macular degeneration and retinitis pigmentosa which affect millions of individuals.

In a study appearing in an advance online publication of the journal Stem Cells on June 15, 2011, investigators used recently developed technology to generate induced pluripotent stem (iPS) cells from a human patient with an uncommon inherited eye disease known as gyrate atrophy. This disorder affects retinal pigment epithelium (RPE) cells, the cells critical to the support of the retina's photoreceptor cells, which function in the transmission of messages from the retina to parts of the brain that interpret images.

"When we generate iPS cells, correct the gene defect that is responsible for this disease, and guide these stem cells to become RPE cells, these RPE cells functioned normally. This is exciting because it demonstrates we can fix something that is out of order. It also supports our belief that in the future, one might be able to use this approach for replacement of cells lost or malfunctioning due to other more common diseases of the retina," said lead study author cell biologist Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis.

Macular degeneration is the most common cause of blindness, affecting an estimated 25-30 million people worldwide. One and a half million people worldwide are affected by retinitis pigmentosa.

Because iPS cells can be derived from the specific patient who needs them, use of these cells may avoid the problem of transplant rejection. In the study, vitamin B-6 also was used to treat the damaged RPE cells producing healthy cells that functioned normally. The retina is a relatively easily accessible part of the central nervous system, which makes it an attractive target for correction with iPS cells. Researchers are hopeful that once the gene defect responsible for a blinding disorder is corrected in iPS cells, these cells may be able to restore vision.

In addition to Meyer of the School of Science at IUPUI, "Optic Vesicle-like Structures Derived from Human Pluripotent Stem Cells Facilitate a Customized Approach to Retinal Disease Treatment" is co-authored by Sara E. Howden, Kyle A. Wallace, Amelia D. Verhoeven, Lynda S. Wright, Elizabeth E. Capowski, Jessica M. Martin, Shulan Tian, Ron Stewart, Bikash Pattnaik, James Thomson and David M. Gamm, all of the University of Wisconsin; and Isabel Pinilla of Blesa University Hospital and the Instituto Aragones de Ciencias de la Salud in Spain. Meyer is also a primary investigator with the Stark Neurosciences Research Institute at Indiana University School of Medicine. Thomson is also associated with the University of California - Santa Barbara.

The School of Science at IUPUI is committed to excellence in teaching, research and service in the biological, physical, behavioral and mathematical sciences. The School is dedicated to being a leading resource for interdisciplinary research and science education in support of Indiana's effort to expand and diversify its economy. For more information visit www.science.iupui.edu

Explore Related Topics

1 - - If you're born blind, you'll likely never have experienced a magic trick, so can we create tricks that could be enjoyed by people with blindness.

2 - - Research finds blinking plays a pivotal role in processing visual information thus adding to a growing body of evidence revising conventional views of vision.

3 - - Scientists revive light-sensing neuron cells in organ donor eyes and restore communication between them as part of a series of discoveries that stand to transform brain and vision research.

4 - - Information and definitions in regards to legal blindness, low vision, total blindness and lack of visual perception due to physiological or neurological factors.

5 - - UNIGE researchers have identified the gene responsible for a recessive genetic disorder that causes degeneration of the eye and blindness.

Complete List of Related Information

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Indiana University-Purdue University Indianapolis School of Science. (2011, June 15). Progress to Reverse Blindness Reported. Disabled World. Retrieved October 6, 2024 from www.disabled-world.com/disability/types/vision/blindness.php

Permalink: <a href="https://www.disabled-world.com/disability/types/vision/blindness.php">Progress to Reverse Blindness Reported</a>: May lead to therapies to reverse blindness caused by common retinal diseases such as macular degeneration and retinitis pigmentosa.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.